ASBP Aspire Biopharma Holdings, Inc.: institutional ownership and insider trading
12 funds reported holding $482K of Aspire Biopharma Holdings, Inc. in their latest 13F filings; in Q2 2026 funds net bought $251K, with 12 new positions and 0 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Largest institutional holders of ASBP
- FNY Investment Advisers, LLC — $231K
- JANE STREET GROUP, LLC — $79.2K
- GEODE CAPITAL MANAGEMENT, LLC — $55.9K
- VANGUARD CAPITAL MANAGEMENT LLC — $55.6K
- VANGUARD FIDUCIARY TRUST CO — $53.8K
- Crewe Advisors LLC — $3.62K
- Tower Research Capital LLC (TRC) — $1.51K
- TORONTO DOMINION BANK (TD, TDBCP) — $886
- Crossingbridge Advisors, LLC — $107
- BARCLAYS PLC (BCS, BCLYF) — $5
Recent ASBP insider trades
- Jun 5, 2025: Fell Donald G. bought 20,000 shares ($7.80K)
5%+ owners
- Lance Friedman: 7.9% (Schedule 13G/A, filed Aug 6, 2026)
- GARY SHIRINYAN: 7.7% (Schedule 13G, filed Aug 10, 2026)
- Rubenbauer Alois Ryan III: 5.0% (Schedule 13G, filed Jul 2, 2026)